- Home
- NRXP vs ANTX Comparison
NRXP vs ANTX Comparison
Compare NRXP & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- ANTX
- Stock Information
- Founded
- NRXP 2015
- ANTX 2017
- Country
- NRXP United States
- ANTX United States
- Employees
- NRXP N/A
- ANTX N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- NRXP Health Care
- ANTX Health Care
- Exchange
- NRXP Nasdaq
- ANTX Nasdaq
- Market Cap
- NRXP 32.6M
- ANTX 33.2M
- IPO Year
- NRXP N/A
- ANTX 2022
- Fundamental
- Price
- NRXP $3.05
- ANTX $1.10
- Analyst Decision
- NRXP Strong Buy
- ANTX Buy
- Analyst Count
- NRXP 4
- ANTX 2
- Target Price
- NRXP $28.50
- ANTX $2.00
- AVG Volume (30 Days)
- NRXP 188.0K
- ANTX 95.4K
- Earning Date
- NRXP 08-13-2025
- ANTX 08-12-2025
- Dividend Yield
- NRXP N/A
- ANTX N/A
- EPS Growth
- NRXP N/A
- ANTX N/A
- EPS
- NRXP N/A
- ANTX N/A
- Revenue
- NRXP N/A
- ANTX N/A
- Revenue This Year
- NRXP N/A
- ANTX N/A
- Revenue Next Year
- NRXP N/A
- ANTX N/A
- P/E Ratio
- NRXP N/A
- ANTX N/A
- Revenue Growth
- NRXP N/A
- ANTX N/A
- 52 Week Low
- NRXP $1.10
- ANTX $0.87
- 52 Week High
- NRXP $6.01
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- NRXP 43.40
- ANTX 48.42
- Support Level
- NRXP $3.12
- ANTX $1.05
- Resistance Level
- NRXP $3.53
- ANTX $1.10
- Average True Range (ATR)
- NRXP 0.16
- ANTX 0.04
- MACD
- NRXP -0.07
- ANTX 0.00
- Stochastic Oscillator
- NRXP 3.92
- ANTX 50.00
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.